Mutational spectrum and classification of novel mutations in patients with metastatic gastrointestinal stromal tumours

In total, ~85% of malignant gastrointestinal stromal tumours (GISTs) harbour activating mutations in one of the genes KIT or PDGFRA, while 10-15% of all GISTs have no detectable KIT or PDGFRA mutations, but could have alterations in genes of the succinate dehydrogenase complex or in BRAF, PIK3CA or...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Oncol
Main Authors: Bombac, Alenka, Zakotnik, Branko, Bucic, Marina, Dragos, Vita Setrajcic, Gazic, Barbara, Stegel, Vida, Klancar, Gasper, Novakovic, Srdjan
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7170035/
https://ncbi.nlm.nih.gov/pubmed/32236636
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2020.5028
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados